Litcius/Paper detail

CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway

Wei Du, F Yin, YATING ZHONG, Minjie Luo, Zhen Wang, Lin Peng, Qing Liu, HAN YANG

2023Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics18 citationsDOIOpen Access PDF

Abstract

Non-small cell lung cancer (NSCLC) is a highly lethal cancer, and better treatments are urgently needed. Many studies have implicated circular RNAs (circRNAs) in the progression of multiple malignant tumors. Nonetheless, the functions of circRNAs in NSCLC remain unclear. To study new targets for the treatment of NSCLC, circRNA expression profiling was performed on NSCLC tissues and para-carcinoma nonmalignant tissues. RNA was isolated and used for circRNA sequencing. Biological studies were performed <i>in vitro</i> and <i>in vivo</i> to determine the functions of circRNAs in NSCLC, including their functions in cell proliferation and migration. How circRNAs function in NSCLC was explored to clarify the underlying regulatory mechanisms. We found that circUCP2 was upregulated in NSCLC tissues compared with neighboring nonmalignant tissues. circUCP2 promoted the proliferation and metastasis of NSCLC cells. circUCP2 promoted NSCLC progression by sponging miR-149 and upregulating UCP2. The circUCP2/miR-149/UCP2 axis accelerates the progression of NSCLC, and circUCP2 may therefore be a novel diagnostic biomarker for the progression of NSCLC.

Topics & Concepts

Lung cancerCancer researchTumor progressionDownregulation and upregulationmicroRNAMetastasisBiomarkerBiologyCircular RNACell growthCancerMedicineOncologyInternal medicineGeneGeneticsBiochemistryCircular RNAs in diseasesMicroRNA in disease regulationCancer-related molecular mechanisms research
CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway | Litcius